- vasculature congestion / MGI
- abnormal vascular development / MGI
- abnormal angiogenesis / MGI
- decreased cell proliferation / MGI
- decreased body length / MGI
- decreased body weight / MGI
- polyphagia / MGI
- internal hemorrhage / MGI
- abnormal somite development / MGI
- decreased embryo size / MGI
- pale yolk sac / MGI
- embryonic growth arrest / MGI
- postnatal growth retardation / MGI
- abnormal lymphatic vessel morphology / MGI
- hemorrhage / MGI
- neoplasm / MGI
- increased circulating insulin level / MGI
- abnormal retinal vasculature morphology / MGI
- no phenotypic analysis / MGI
- abnormal vitelline vasculature morphology / MGI
- increased pancreatic beta cell number / MGI
- decreased lean body mass / MGI
- abnormal endocardium morphology / MGI
- embryonic growth retardation / MGI
- abnormal vitelline vascular remodeling / MGI
- fetal growth retardation / MGI
- decreased incidence of tumors by chemical induction / MGI
- abnormal anterior cardinal vein morphology / MGI
- abnormal dorsal aorta morphology / MGI
- decreased skeletal muscle mass / MGI
- abnormal brain vasculature morphology / MGI
- impaired glucose tolerance / MGI
- insulin resistance / MGI
- abnormal cell physiology / MGI
- increased circulating leptin level / MGI
- increased fat cell size / MGI
- abnormal lymphangiogenesis / MGI
- mortality/aging / MGI
- postnatal lethality, incomplete penetrance / MGI
- neonatal lethality, incomplete penetrance / MGI
- embryonic lethality, complete penetrance / MGI
- embryonic lethality during organogenesis, complete penetrance / MGI
- chylous ascites / MGI
- abnormal intersomitic vessel morphology / MGI
- abnormal perineural vascular plexus morphology / MGI
B6.129P2-Pik3catm3Bvan/Orl
Status | Available to order |
EMMA ID | EM:11394 |
International strain name | B6.129P2-Pik3catm3Bvan/Orl |
Alternative name | B6.129P2-Pik3catm1Bvan/J |
Strain type | Targeted Mutant Strains : Conditional mutation |
Allele/Transgene symbol | Pik3catm3Bvan |
Gene/Transgene symbol | Pik3ca |
Information from provider
Provider | Bart Vanhaesebroeck |
Provider affiliation | UCL Cancer Institute, University College London |
Additional owner | the University of Edinburgh |
Genetic information | Exons 18 and 19 of the Pik3ca (PIK3CA/p110alpha) gene are flanked by loxP sites; backcrossed to C57BL/6J background. |
Phenotypic information | Homozygous:Mice are phenotypically normal.Heterozygous:Mice are phenotypically normal. |
Breeding history | Backcrossed to C57BL/6J for more than 10 generations. |
References |
|
Homozygous fertile | yes |
Homozygous viable | yes |
Homozygous matings required | no |
Immunocompromised | no |
Information from EMMA
Archiving centre | Institut de Transgenose, INTRAGENE, Orléans, France |
Disease and phenotype information
Orphanet associated rare diseases, based on orthologous gene matching
- Macrodactyly of toes, unilateral / Orphanet_295243
- Adult hepatocellular carcinoma / Orphanet_210159
- Hemimegalencephaly / Orphanet_99802
- Hemihyperplasia-multiple lipomatosis syndrome / Orphanet_276280
- Segmental progressive overgrowth syndrome with fibroadipose hyperplasia / Orphanet_314662
- CLOVES syndrome / Orphanet_140944
- Megalencephaly-capillary malformation-polymicrogyria syndrome / Orphanet_60040
- Macrodactyly of fingers, unilateral / Orphanet_295239
- Cowden syndrome / Orphanet_201
- Meningioma / Orphanet_2495
MGI phenotypes (gene matching)
Literature references
- Angiogenesis selectively requires the p110alpha isoform of PI3K to control endothelial cell migration.;Graupera Mariona, Guillermet-Guibert Julie, Foukas Lazaros C, Phng Li-Kun, Cain Robert J, Salpekar Ashreena, Pearce Wayne, Meek Stephen, Millan Jaime, Cutillas Pedro R, Smith Andrew J H, Ridley Anne J, Ruhrberg Christiana, Gerhardt Holger, Vanhaesebroeck Bart, ;2008;Nature;453;662-6; 18449193
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).